Les déterminants des fusions-acquisitions. Le cas de l'industrie pharmaceutique

Gautier Duflos and Étienne Pfister

Revue économique, 2007, vol. 58, issue 3, 577-586

Abstract: This article considers the determinants of the corporate acquisitions made in the American pharmaceutical industry between 1978 and 2002. We seek to evaluate the robustness of the ?pipeline gap? hypothesis through a larger, more exhaustive sample, and extend it to patent data. In line with the pipeline gap hypothesis, estimations from a Cox duration model show that the Tobin?s q exerts a negative in?uence on the decision to acquire another pharmaceutical ?rm. On the other hand, several indicators of patent quality have a positive in?uence, indicating that acquiring ?rms also have a signi?cant innovative potential. Classi?cation JEL : L13, L65

JEL-codes: L13 L65 (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=RECO_583_0577 (application/pdf)
http://www.cairn.info/revue-economique-2007-3-page-577.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:recosp:reco_583_0577

Access Statistics for this article

More articles in Revue économique from Presses de Sciences-Po
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().